Table 6.
Growth inhibition studies were performed as described for Table 3. Cells were incubated in serial dilutions of 4da for 3 days before determining viable cell numbers relative to untreated cells.
| Cell Line or Strain |
Cell Type | Inhibition (IC50, µM) |
|---|---|---|
| H460 | lung cancer | 15.9 ± 1.1 |
| HeLa | uterine cervical cancer | 10.8 ± 0.8 |
| HEK-293 | embryonic kidney | 10.4 ± 1.3 |
| JJN3 | myeloma | 15.7 ± 0.9 |
| INA-6 | myeloma | 18.1 ± 0.8 |
| IH-1 | myeloma | 20.6 ± 1.1 |
| ANBL-6 | myeloma | 35.6 ± 2.6 |
| KJON | myeloma | 23.0 ± 2.6 |
| U266 | myeloma | 46.0 ± 3.2 |
| HO15.19 (myc−/−) | rat fibroblasts | 20.6 ± 1.0 |
| HO15.19-wt-Myc | rat fibroblasts | 14.1 ± 1.2 |